Taysha Gene Therapies: Astellas Throws Lifeline For On Rett And GAN Programs (NASDAQ:TSHA)
Artur PlawgoShares of Taysha Gene Therapies (NASDAQ:TSHA) have fallen by 85% since the September 2020 IPO was priced at $20. ...
Artur PlawgoShares of Taysha Gene Therapies (NASDAQ:TSHA) have fallen by 85% since the September 2020 IPO was priced at $20. ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.